Related Experiment Video
Updated: Dec 12, 2025

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
Brain tumour patients' use of social media for disease management: Current practices and implications for the future
Heidi McAlpine1, Magdalena Sejka1, Katharine J Drummond2
1Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, Australia.
Objective:
The role of social media in disease management is evolving. We aimed to define current use of social media for patients with primary brain tumours.
Methods:
This was a single-centre cross-sectional prospective study; a questionnaire was administered on electronic tablets to patients in the Outpatient Department of Royal Melbourne Hospital.
Results:
Of the 201 participants, 55.7 % were female and 61.2 % were aged 30-59 years. The Internet was used by 84.5 % of participants, 70.6 % of those used social media. This included social networking sites (33.1 %), wikis (28.1 %) and blogs (14.0 %) to access information, for communication or for interaction related to their brain tumour. Participants indicated preferences for privacy and flexibility and valued when health professionals contributed. Subjective social functioning and activities of daily living benefits were reported from use, however no difference in Health Related Quality of Life was found between social media users and non-users.
Conclusions:
This study is the first to examine social media use in disease management for brain tumour patients and defines its use and potential for targeted online interventions.
Practice Implications:
Through identifying concerns regarding current social media sites and determining preferences of patients we have created recommendations to direct design of online content for patients.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cancer Survival Analysis
Tumor Immunotherapy

